These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15948027)

  • 21. High levels of circulating neutralizing antibody in normal animals to recombinant mouse interferon-beta produced in yeast.
    Sedmak JJ; Grossberg SE
    J Interferon Res; 1989 Sep; 9 Suppl 1():S61-5. PubMed ID: 2809279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel mouse model for evaluation and prediction of HLA-A2-restricted CEA cancer vaccine responses.
    Conforti A; Peruzzi D; Giannetti P; Biondo A; Ciliberto G; La Monica N; Aurisicchio L
    J Immunother; 2009 Sep; 32(7):744-54. PubMed ID: 19561534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity of an interferon-beta1a product.
    Kauffman MA; Sterin-Prync A; Papouchado M; González E; Vidal AJ; Grossberg SE; Chuppa S; Odoriz B; Vrech C; Diez RA; Ferro HH
    Int J Immunopathol Pharmacol; 2011; 24(2):499-504. PubMed ID: 21658324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenicity of different stressed IgG monoclonal antibody formulations in immune tolerant transgenic mice.
    Filipe V; Jiskoot W; Basmeleh AH; Halim A; Schellekens H; Brinks V
    MAbs; 2012; 4(6):740-52. PubMed ID: 22951518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of the immunogenicity of different interferon beta-1a formulations using ex vivo T-cell assays.
    Jaber A; Baker M
    J Pharm Biomed Anal; 2007 Mar; 43(4):1256-61. PubMed ID: 17118612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteins.
    Satoi J; Murata K; Lechmann M; Manickan E; Zhang Z; Wedemeyer H; Rehermann B; Liang TJ
    J Virol; 2001 Dec; 75(24):12121-7. PubMed ID: 11711603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of antigenic domains on natural and recombinant human IFN-beta by the inhibition of biologic activities with monoclonal antibodies.
    Redlich PN; Grossberg SE
    J Immunol; 1989 Sep; 143(6):1887-93. PubMed ID: 2476486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune rejection in a humanized model of murine prostate cancer.
    Schaue D; Koya RC; Liao YP; Ribas A; McBride WH
    Anticancer Res; 2010 Feb; 30(2):409-14. PubMed ID: 20332447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IgG-Mediated Immune Suppression to Erythrocytes by Polyclonal Antibodies Can Occur in the Absence of Activating or Inhibitory Fcγ Receptors in a Full Mouse Model.
    Bernardo L; Yu H; Amash A; Zimring JC; Lazarus AH
    J Immunol; 2015 Sep; 195(5):2224-30. PubMed ID: 26188060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Partial tolerance in beta-galactosidase-transgenic mice.
    Theopold U; Köhler G
    Eur J Immunol; 1990 Jun; 20(6):1311-6. PubMed ID: 2114998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of chimeric HBc proteins with epitopes in E.coli: formation of virus-like particles and a potent inducer of antigen-specific cytotoxic immune response and anti-tumor effect in vivo.
    Zhang Y; Song S; Liu C; Wang Y; Xian X; He Y; Wang J; Liu F; Sun S
    Cell Immunol; 2007 May; 247(1):18-27. PubMed ID: 17707782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Individual mouse analysis of the cellular immune response to tumor antigens in peripheral blood by intracellular staining for cytokines.
    Giannetti P; Facciabene A; La Monica N; Aurisicchio L
    J Immunol Methods; 2006 Oct; 316(1-2):84-96. PubMed ID: 17010367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural antibodies to interferon-alpha and interferon-beta are a common feature of inbred mouse strains.
    De Maeyer-Guignard J; De Maeyer E
    J Immunol; 1986 Mar; 136(5):1708-11. PubMed ID: 3950401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation of Hybridomas producing monoclonal antibodies against human interferon.
    Andzhaparidze OG; Nagieva FG; Pille ER; Nikulina VG; Barkova EP; Etkind GV; Melnikova NL; Khats YuS ; Sidorova EV
    Acta Virol; 1988 Nov; 32(6):481-6. PubMed ID: 2906219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mapping T and B cell epitopes in sperm protein 17 to support the development of an ovarian cancer vaccine.
    Xiang SD; Gao Q; Wilson KL; Heyerick A; Plebanski M
    Vaccine; 2015 Nov; 33(44):5950-9. PubMed ID: 26263201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of the parenteral route of administration on the immune response to simultaneous nasal and parenteral immunizations using a new HBV therapeutic vaccine candidate.
    Lobaina Y; Trujillo H; García D; Gambe A; Chacon Y; Blanco A; Aguilar JC
    Viral Immunol; 2010 Oct; 23(5):521-9. PubMed ID: 20883166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tolerance induced by physiological levels of secreted proteins in transgenic mice expressing human insulin.
    Whiteley PJ; Lake JP; Selden RF; Kapp JA
    J Clin Invest; 1989 Nov; 84(5):1550-4. PubMed ID: 2681269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The immunogenicity of antibody aggregates in a novel transgenic mouse model.
    Bessa J; Boeckle S; Beck H; Buckel T; Schlicht S; Ebeling M; Kiialainen A; Koulov A; Boll B; Weiser T; Singer T; Rolink AG; Iglesias A
    Pharm Res; 2015 Jul; 32(7):2344-59. PubMed ID: 25630815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extensive Chemical Modifications in the Primary Protein Structure of IgG1 Subvisible Particles Are Necessary for Breaking Immune Tolerance.
    Boll B; Bessa J; Folzer E; Ríos Quiroz A; Schmidt R; Bulau P; Finkler C; Mahler HC; Huwyler J; Iglesias A; Koulov AV
    Mol Pharm; 2017 Apr; 14(4):1292-1299. PubMed ID: 28206769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.